Analyst Expectations For Phreesia's Future
Portfolio Pulse from Benzinga Insights
Recent analyst ratings for Phreesia (NYSE:PHR) show a mix of bullish to indifferent sentiments, with an average 12-month price target of $31.67, down from $34.00. The company's financial performance includes a 25.33% revenue growth rate and a net margin of -34.86%. Phreesia's market position is strengthened by its comprehensive software solutions for healthcare organizations, despite a market capitalization and ROA below industry averages.
March 15, 2024 | 2:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Phreesia's mixed analyst ratings and revised price target reflect cautious optimism. Its strong revenue growth and comprehensive healthcare solutions position it positively, despite some financial challenges.
The mixed analyst ratings indicate a cautious but optimistic outlook for Phreesia. The decrease in the average price target suggests some concerns, but the company's significant revenue growth and its role in healthcare through its software solutions could drive positive sentiment among investors. The financial challenges such as below-average market capitalization and ROA are noted, but the strong revenue growth and net margin are likely to outweigh these concerns in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100